Targeting Tumors with Salmonella Typhimurium- Potential for Therapy

作者: Daniel M. Wall , C.V. Srikanth , Beth A. McCormick

DOI: 10.18632/ONCOTARGET.206

关键词:

摘要: Received: December 23, 2010 , Accepted: 29, Published: January 3, // When one considers the organism Salmonella enterica serotype Typhimurium (S. Typhimurium), usually thinks of Gram-negative enteric pathogen that causes severe food borne illness, gastroentertitis. In this context, idea being exploited as a cancer therapeutic seems pretty remote. However, there has been an escalating interest in development tumor-therapeutic bacteria for use treatment variety cancers. This strategy takes advantage remarkable ability certain to preferentially replicate and accumulate within tumors. case S. Typhimurium, infects selectively grows implanted tumors, achieving tumor/normal tissue ratios approximately 1,000:1. also some attractive properties well suited design chemotherapeutic agent. particular, can easily be manipulated carry foreign genes, since species is facultative anaerobe, it able survival both oxygenated hypoxic conditions, implying could colonize small metastatic lesions larger These observations are impetus burgeoning field focused on clinically useful anti-cancer We will discuss three cutting edge technologies employing target

参考文章(63)
Bentham Science Publisher Bentham Science Publisher, Clostridial spores to treat solid tumours - potential for a new therapeutic modality. Current Gene Therapy. ,vol. 10, pp. 15- 26 ,(2010) , 10.2174/156652310790945548
Kenneth Brooks Low, Martina Ittensohn, Xiang Luo, Li-Mou Zheng, Ivan King, John M. Pawelek, David Bermudes, Construction of VNP20009: A Novel, Genetically Stable Antibiotic-Sensitive Strain of Tumor-Targeting Salmonella for Parenteral Administration in Humans Suicide Gene Therapy. ,vol. 90, pp. 47- 60 ,(2004) , 10.1385/1-59259-429-8:47
Ivan King, Martina Itterson, David Bermudes, Tumor-targeted Salmonella typhimurium overexpressing cytosine deaminase: a novel, tumor-selective therapy. Methods of Molecular Biology. ,vol. 542, pp. 649- 659 ,(2009) , 10.1007/978-1-59745-561-9_33
Edward F McCarthy, The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. The Iowa orthopaedic journal. ,vol. 26, pp. 154- 158 ,(2006)
Markus Loeffler, Gaelle Le’Negrate, Maryla Krajewska, John C. Reed, Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth Cancer Immunology, Immunotherapy. ,vol. 58, pp. 769- 775 ,(2009) , 10.1007/S00262-008-0555-9
B Hu, L Kou, C Li, L-P Zhu, Y-R Fan, Z-W Wu, J-J Wang, G-X Xu, Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth Cancer Gene Therapy. ,vol. 16, pp. 655- 663 ,(2009) , 10.1038/CGT.2009.7
Robert M. Hoffman, Tumor-targeting amino acid auxotrophic Salmonella typhimurium Amino Acids. ,vol. 37, pp. 509- 521 ,(2009) , 10.1007/S00726-009-0261-8
R.W. Carey, J.F. Holland, H.Y. Whang, E. Neter, B. Bryant, Clostridial oncolysis in man European Journal of Cancer (1965). ,vol. 3, pp. 37- 46 ,(1967) , 10.1016/0014-2964(67)90060-6
Mario Sznol, Stanley L. Lin, David Bermudes, Li-mou Zheng, Ivan King, Use of preferentially replicating bacteria for the treatment of cancer Journal of Clinical Investigation. ,vol. 105, pp. 1027- 1030 ,(2000) , 10.1172/JCI9818
Neil S. Forbes, Engineering the perfect (bacterial) cancer therapy Nature Reviews Cancer. ,vol. 10, pp. 785- 794 ,(2010) , 10.1038/NRC2934